Aesthetic Device Safety Patents: Who Leads, Where the Gaps Are 2026
Aesthetic device safety and skin typing patents: mapping who controls fluence, cooling and consent claims
Concentrated at the top. The five leading assignees hold 107 of 294 records in scope (36.4%), and the leading ten hold 165 (56.1%) — a dense core with a long tail of single- and few-filing entrants behind it. Filings moved from 7 in 2017 to a peak of 28 in 2024, with 2021-2024 alone showing a 12% rise. 2025 and 2026 figures are undercounted because publication typically lags filing by around 18 months — treat the tail of the chart as incomplete, not as a slowdown.
- 1GALDERMA RESEARCH & DEVELOPMENT SNC51
- 2FA CORP15
- 3TRIA BEAUTY INC14
- 4BOARD OF RGT THE UNIV OF TEXAS SYST14
- 5HUANG LI13
See the full aesthetic device safety and skin typing analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions on this landscape
Who holds the most patents in aesthetic device safety and skin typing?
One assignee leads clearly with 51 of the 294 records in scope, more than four times the fifth-place count of 13. The leading five assignees together hold 107 records (36.4% of the field) and the leading ten hold 165 (56.1%), so the field is concentrated at the top with a long tail of entrants filing only a handful of records each. Anyone entering this space should check that leader’s portfolio first before drafting new claims.
Is filing activity in this area growing or slowing down?
Filings rose from 25 in 2021 to 28 in 2024, a 12% increase over that span, with 2024 the peak year in the dataset. Figures for 2025 and 2026 appear lower, but that reflects the roughly 18-month lag between filing and publication rather than an actual slowdown. The last year that can be read as a complete signal is 2024, and it shows continued growth, not contraction.
What technology areas carry the most patent claim density?
A61K medicinal-preparation classifications appear in 58.8% of the 294 records, the highest of any IPC subclass tracked, followed by A61P therapeutic-activity claims at 29.9% and A61B diagnosis-and-surgery claims at 27.2%. A61N electrotherapy/radiation and A61Q cosmetics-use claims trail at 16.7% and 16.3%. Because a single record can carry multiple IPC codes, these percentages describe claim-space occupation rather than a strict breakdown of the field.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Aesthetic Device Safety and Skin Typing covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.